Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology Reports|March 21, 2017
The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-upErica Huelsmann, Israel Zighelboim, Amina Ahmed, et al.
Journal of the National Cancer Institute|August 1, 1982
Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in miceA Lichtenstein, R Tuttle, J Cantrell, et al.
Gynecologic Oncology Reports|October 27, 2018
Renocolic fistula secondary to curative intent extended field radiotherapy for cervical cancerDhanalakshmi Thiyagarajan, Michael Hughes, Frank Tamarkin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cellsY Nio, J Zighelboim, J Berek, et al.
Digestive Diseases and Sciences|January 1, 1995
Abnormalities in the shape of the duodenal loop on X-ray. Associated with idiopathic antral hypomotility?J Zighelboim, R L MacCarty, N J Talley
American Journal of Therapeutics|July 1, 1997
Onset and duration of analgesia of diclofenac potassium in the treatment of postepisiotomy painN Z Olson, A Sunshine, I Zighelboim, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 11, 1999
Analgesic efficacy of liquid ketoprofen compared to liquid dipyrone and placebo administered orally as drops in postepisiotomy painN Z Olson, A Sunshine, I Zighelboim, et al.
Blood|June 1, 1980
Severe platelet dysfunction in hairy cell leukemia with improvement after splenectomyM H Rosove, F Naeim, S Harwig, et al.
Cancer Research|November 1, 1984
Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in miceA K Lichtenstein, J Berek, J Kahle, et al.
Gynecologic Oncology|September 1, 1990
Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cellsB Bonavida, T Tsuchitani, J Zighelboim, et al.
Pageof 14